State leaders laud Taubman Institute accomplishments

 

Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.

Meeting with Taubman Institute Founder and Chair A. Alfred Taubman and Director Dr. Eva Feldman were state Senate Majority Leader Randy Richardville, Oakland County Executive L. Brooks Patterson and George Miller, director of the Oakland County Department of Health and Human Services. They were joined by Cynthia Wilbanks, U-M’s vice president for government relations, and Linden Nelson, a Michigan entrepreneur.

The promise of stem cells for the treatment of disease was among the topics discussed. Dr. Feldman gave an update on her landmark trial of a new stem cell therapy for ALS, and Dr. Gary Smith, director of the MStem Cell Laboratories (U-M’s newly renamed stem cell derivation lab), told the visitors about the 16 new stem cell lines that MStem has developed – including one that carries the gene for hypertrophic cardiomyopathy, a heart defect that often strikes down young athletes.

The cells from that line can be grown into heart cells that actually beat on their own in the petri dish, Dr. Smith said, and thus allow physicians to study the progression of the disease in ways that aren’t possible on human subjects.

“I have always been a staunch believer in the promise of stem cells to alleviate disease, and the scientists we support through the Taubman Institute continue to amaze me, their own colleagues and the entire scientific community with the remarkable results of their visionary research,” said Mr. Taubman.

Following an update by Max Wicha’s, a Taubman Scholar and director of U-M’s Comprehensive Cancer Center, on his pioneering clinical trials targeting cancer stem cells, the group traveled to U-M’s North Campus Research Complex for a tour of the 2.1 million square-foot facility, including Dr. Wicha’s new state-of-the-art cancer research lab.

“It’s amazing to see the world class research happening right in our own backyard,” said Sen. Richardville. “The University of Michigan's Taubman Institute is leading the world in medical research for diseases like cancer and ALS. They are truly ‘the Leaders and the Best.’"

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists